First Horizon Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Buy |
5,269
+36
| +0.7% | +$9.79K | 0.04% | 228 |
|
|
2025
Q1 | $1.39M | Sell |
5,233
-4
| -0.1% | -$987 | 0.04% | 224 |
|
|
2024
Q4 | $1.22M | Buy |
5,237
+31
| +0.6% | +$7.13K | 0.03% | 237 |
|
|
2024
Q3 | $1.15M | Sell |
5,206
-273
| -5% | -$56.5K | 0.03% | 244 |
|
|
2024
Q2 | $1.08M | Sell |
5,479
-31
| -0.6% | -$6.41K | 0.03% | 244 |
|
|
2024
Q1 | $1.19M | Sell |
5,510
-92
| -2% | -$19.3K | 0.04% | 232 |
|
|
2023
Q4 | $1.18M | Buy |
5,602
+182
| +3% | +$38.8K | 0.04% | 233 |
|
|
2023
Q3 | $1.09M | Buy |
5,420
+4
| +0.1% | +$795 | 0.04% | 236 |
|
|
2023
Q2 | $1M | Buy |
5,416
+21
| +0.4% | +$3.88K | 0.03% | 256 |
|
|
2023
Q1 | $1.03M | Buy |
5,395
+4,854
| +897% | +$878K | 0.04% | 257 |
|
|
2022
Q4 | $91K | Buy |
541
+151
| +39% | +$26.2K | ﹤0.01% | 648 |
|
|
2022
Q3 | $69K | Sell |
390
-163
| -29% | -$32.2K | ﹤0.01% | 725 |
|
|
2022
Q2 | $112K | Buy |
553
+236
| +74% | +$50K | ﹤0.01% | 626 |
|
|
2022
Q1 | $75K | Sell |
317
-97
| -23% | -$22.8K | ﹤0.01% | 544 |
|
|
2021
Q4 | $94K | Sell |
414
-36
| -8% | -$7.92K | ﹤0.01% | 697 |
|
|
2021
Q3 | $86K | Buy |
450
+238
| +112% | +$48.2K | ﹤0.01% | 721 |
|
|
2021
Q2 | $45K | Sell |
212
-44
| -17% | -$9.29K | ﹤0.01% | 822 |
|
|
2021
Q1 | $52K | Buy |
256
+22
| +9% | +$4.33K | ﹤0.01% | 727 |
|
|
2020
Q4 | $42K | Sell |
234
-12
| -5% | -$2.04K | ﹤0.01% | 662 |
|
|
2020
Q3 | $41K | Buy |
246
+55
| +29% | +$9.26K | ﹤0.01% | 592 |
|
|
2020
Q2 | $30K | Buy |
191
+7
| +4% | +$1.25K | ﹤0.01% | 662 |
|
|
2020
Q1 | $31K | Buy |
184
+3
| +2% | +$597 | ﹤0.01% | 588 |
|
|
2019
Q4 | $35K | Buy |
181
+12
| +7% | +$2.46K | ﹤0.01% | 665 |
|
|
2019
Q3 | $34K | Sell |
169
-1,249
| -88% | -$261K | ﹤0.01% | 652 |
|
|
2019
Q2 | $275K | Buy |
1,418
+1,260
| +797% | +$232K | 0.02% | 297 |
|
|
2019
Q1 | $26K | Buy |
158
+34
| +27% | +$6.01K | ﹤0.01% | 726 |
|
|
2018
Q4 | $22K | Sell |
124
-77
| -38% | -$14.2K | ﹤0.01% | 752 |
|
|
2018
Q3 | $34K | Buy |
201
+8
| +4% | +$1.35K | ﹤0.01% | 690 |
|
|
2018
Q2 | $31K | Sell |
193
-70
| -27% | -$11.4K | ﹤0.01% | 732 |
|
|
2018
Q1 | $43K | Sell |
263
-54
| -17% | -$8.6K | ﹤0.01% | 531 |
|
|
2017
Q4 | $47K | Buy |
317
+58
| +22% | +$8.26K | ﹤0.01% | 535 |
|
|
2017
Q3 | $35K | Hold |
259
| – | – | ﹤0.01% | 589 |
|
|
2017
Q2 | $32K | Sell |
259
-9
| -3% | -$1.08K | ﹤0.01% | 606 |
|
|
2017
Q1 | $31K | Buy |
268
+138
| +106% | +$16.6K | ﹤0.01% | 673 |
|
|
2016
Q4 | $13K | Hold |
130
| – | – | ﹤0.01% | 915 |
|
|
2016
Q3 | $13K | Buy |
130
+46
| +55% | +$4.8K | ﹤0.01% | 907 |
|
|
2016
Q2 | $8K | Buy |
+84
| New | +$7.94K | ﹤0.01% | 1011 |
|
|
2016
Q1 | – | Sell |
-15
| Closed | -$1K | – | 1334 |
|
|
2015
Q4 | $1K | Hold |
15
| – | – | ﹤0.01% | 1196 |
|
|
2015
Q3 | $1K | Hold |
15
| – | – | ﹤0.01% | 1334 |
|
|
2015
Q2 | $1K | Buy |
+15
| New | +$1.4K | ﹤0.01% | 1356 |
|
|
2014
Q1 | – | Sell |
-4
| Closed | – | – | 1386 |
|
|
2013
Q4 | $0 | Buy |
+4
| New | +$313 | ﹤0.01% | 1329 |
|
Other funds holding CME
First Horizon Advisors's CME Position: Q2 2025 in Review
First Horizon Advisors increased its CME Group (CME) stake by 0.69% in Q2 2025, buying an estimated $9.79K and bringing the position to 5,269 shares worth $1.45M. The position accounts for 0.04% of the portfolio, ranked #228.
First Horizon Advisors first reported a position in CME in Q4 2013 and has held it in 41 quarters since. 1,661 funds tracked by Wall St. Rank hold CME as of Q2 2025.
- First Horizon Advisors held 5,269 shares of CME Group worth $1.45M as of Q2 2025.
- First Horizon Advisors bought 36 CME Group shares in Q2 2025, an estimated $9.79K.
- CME Group made up 0.04% of First Horizon Advisors's portfolio in Q2 2025, its #228 holding.
- First Horizon Advisors first reported a position in CME Group in Q4 2013 and has held it in 41 quarters since.
- 1,661 funds tracked by Wall St. Rank held CME Group as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.